Murray Stewart
CIK 1723450 · Interim Chief Medical Officer · last filed 2026-01-05
Murray Stewart is an Interim Chief Medical Officer who has filed 18 SEC Form 4 insider transactions across 5 companies since 2017. The most recent filing, for XFOR, was dated Jan 5, 2026. Across all open-market trades the lifetime net is −$137.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $31.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$31.5K
5
18
-$137.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XFOR | Interim Chief Medical Officer | 7,883 | $4.00 | $31.5K | -$137.9K | 9 | 2026-01-05 |
| CAMP | Director | — | $4.19 | — | $0 | 1 | 2025-03-19 |
| AMRN | Director | — | $15.24 | — | $0 | 1 | 2023-01-12 |
| RYTM | Chief Medical Officer | — | $88.38 | — | $0 | 5 | 2021-02-16 |
| NOVELION THERAPEUTICS INC. (NVLN) Delisted | Executive Vice President, R&D | 50,000 | — | — | $0 | 2 | 2018-02-14 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-05 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2025-06-10 | XFOR | Grant (A) | +1,500 | $0 | EDGAR |
| 2025-03-19 | CAMP | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | XFOR | Grant (A) | +45,000 | $0 | EDGAR |
| 2023-08-11 | XFOR | Mixed | +139,837 | -$137.9K | EDGAR |
| 2023-01-12 | AMRN | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | XFOR | Grant (A) | +6,667 | $0 | EDGAR |
| 2021-06-02 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2021-02-16 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2020-10-21 | XFOR | Grant (A) | — | $0 | EDGAR |